Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/17/1991 | US5049546 Fungicides |
09/17/1991 | US5049378 Prevention and treatment of porcine haemophilus pneumonia (PHP) |
09/17/1991 | CA2038411A1 3-tetrazolylthiomethyl cephalosporin antibiotics |
09/16/1991 | WO1991013909A1 Synthetic polypeptides |
09/16/1991 | CA2078220A1 Synthetic polypeptides |
09/14/1991 | WO1991013886A1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE |
09/14/1991 | CA2357062A1 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1, 3-propanediols and related compounds, a process and intermediates for their preparation and their use as medicaments |
09/14/1991 | CA2078148A1 Pharmaceutically active compounds which can be formed from 1,3,4,6,7,8-hexahydro- 2h-pyrimido-(1,2a)-pyrimidine |
09/13/1991 | WO1991013995A1 Recombinant herpesviruses in particular for the production of vaccines, their preparation process, plasmides produced during this process and the vaccines obtained |
09/13/1991 | CA2055489A1 Recombinant herpesviruses in particular for the production of vaccines, their preparation process, plasmides produced during this process and the vaccines obtained |
09/13/1991 | CA2037957A1 N-acylated cyclohexapeptide compounds |
09/11/1991 | EP0445925A1 1-Carba(dethia)caphalosporin antibiotics |
09/11/1991 | EP0445743A2 Complexes and chelates of azithromycin as antiulcer drugs |
09/11/1991 | EP0445581A1 Stable immunostimulating preparation for parenteral application, preparation and use thereof |
09/11/1991 | EP0445229A1 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
09/11/1991 | EP0445201A1 Nucleoside analogues |
09/11/1991 | EP0445145A1 Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon |
09/11/1991 | EP0368953A4 Method and microorganism for the production of faeriefungin |
09/10/1991 | WO1991013910A1 Peptides stimulating cytotoxic t cells immune to hiv rt |
09/10/1991 | WO1991013906A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
09/10/1991 | US5047407 Prevention Or Treatment Of Human Immunodeficiency Virus |
09/10/1991 | US5047400 Treatment of infection; antitumor agents |
09/10/1991 | CA1288764C Cephalosporin compounds |
09/07/1991 | WO1991013549A1 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections |
09/07/1991 | CA2053849A1 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections |
09/07/1991 | CA2037531A1 Preparation, which stimulates the immune system, can be applied parenterally and has a long shelf life, and method forproducing it |
09/05/1991 | WO1991012811A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
09/05/1991 | WO1991011525A3 Vaccines |
09/05/1991 | DE4005630A1 Monoclonal antibodies against tumour-associated antigens - specifically MAB BW SCLC-1 and MAB BW SCLC-2, used in immune therapy and treatment and diagnosis of tumours |
09/05/1991 | CA2074523A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
09/04/1991 | EP0445098A2 Deoxynojirimycin derivatives as antiviral agents |
09/04/1991 | EP0444889A1 Novel synthesis of carbapenem intermediates |
09/04/1991 | EP0444638A2 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus |
09/04/1991 | EP0444560A1 Antibody specific for the tumor necrosis factor receptor |
09/03/1991 | WO1991012792A1 Method and product for promoting hair growth and treating skin conditions |
09/03/1991 | US5045549 Bactericides |
09/03/1991 | US5045541 Immunodeficiency disorders |
09/03/1991 | US5045530 Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders |
09/03/1991 | US5045320 Large multivalent immunogen |
09/03/1991 | US5045318 Anti-inflammatory oxidizing agent, the procedure for its production and various applications |
09/03/1991 | US5045306 N-alkylamides of D,L and L(-)-carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same |
09/03/1991 | US5045104 Bactericides, algicides, fungicides |
09/01/1991 | CA2018388A1 Therapeutic agent for tinea |
08/29/1991 | WO1991013088A1 Terminally blocked antiviral peptides |
08/29/1991 | DE4006269A1 Antibody which binds to tumour necrosis factor receptors |
08/29/1991 | CA2077088A1 Terminally blocked antiviral peptides |
08/29/1991 | CA2037200A1 Water soluble salts of purpuromycin and pharmaceutical formulations thereof |
08/28/1991 | EP0443891A1 Use of N-myristoyl-(S)-phenylalanine for the preparation of a medicament for the treatment of disorders by inhibiting the myristoylation |
08/28/1991 | EP0443719A1 Novel R106 compounds |
08/28/1991 | EP0443654A2 Antibiotic agent |
08/28/1991 | EP0443599A2 Monoclonal antibodies specific for tumor-associated antigens, method for their preparation and their use |
08/28/1991 | EP0443573A2 HIV protease inhibitors containing derived amino acids |
08/28/1991 | EP0443560A2 HIV protease inhibitors |
08/28/1991 | EP0443559A2 HIV protease inhibiting agents |
08/28/1991 | EP0443471A1 2'-Deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
08/28/1991 | EP0443404A1 Peptide fragments and analogs of thrombospondin |
08/28/1991 | EP0443335A1 Recombinant pox virus plasmid containing a multi-functional DNA cassette |
08/28/1991 | EP0443090A2 Agent for preventing infection with methicillin-resistant staphylococcus |
08/28/1991 | EP0443021A1 Novel use of vitamin d compounds to inhibit replication of the aids virus |
08/28/1991 | EP0164403B1 Feline leukemia virus vaccine |
08/28/1991 | CN1013687B Tricycle compounds, a process for their production and a pharmaceutical composition containing the same |
08/27/1991 | US5043450 8-alkoxyquinolonecarboxylic acid and salts thereof |
08/27/1991 | US5043440 Oxidation process for preparing 4-acyloxy azetidinones in a two-phase system |
08/27/1991 | US5043437 5'phosphonates of 3'-azido-2',3'dideoxynucleosides |
08/27/1991 | US5043357 Virucidal agent having broad-spectrum activity |
08/27/1991 | US5043339 Oral delivery for lower dosage; herpes, cytomegalo viruses |
08/27/1991 | US5043334 Cephalosporin antibiotics |
08/27/1991 | US5043324 Macrolide compounds |
08/27/1991 | US5043273 Phosphorylated glycosidase inhibitor prodrugs |
08/27/1991 | US5043156 Method of treating infectious diseases with granulocyte colony-stimulating factor |
08/27/1991 | CA2036964A1 Method of antiviral enhancement |
08/27/1991 | CA2036960A1 Novel synthesis of carbapenem intermediates |
08/27/1991 | CA1288098C 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity |
08/27/1991 | CA1288091C 6-.beta.(SUBSTITUTED)-(S)-HYDROXYMETHYLPENICILLANIC ACIDS AND DERIVATIVES THEREOF |
08/27/1991 | CA1288050C Nitrofurantoin dosage form |
08/24/1991 | WO1991012815A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO β-LACTAM ANTIBIOTICS |
08/24/1991 | CA2076529A1 Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
08/23/1991 | WO1991012804A1 New use |
08/23/1991 | CA2036093A1 Peptide fragments and analogs of thrombospondin |
08/22/1991 | WO1991012269A1 Immunologically active peptides or polypeptides from the parvovirus b19 |
08/22/1991 | WO1991012015A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell |
08/22/1991 | WO1991012012A1 An antiviral agent derived from the hull of the kukui nut |
08/22/1991 | DE4005275A1 Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren Use of S-adenosylmethionine as an agent against viral infections by retroviruses |
08/21/1991 | WO1991012809A1 Use of s-adenosyl methionine as an agent against viral infections by retroviruses |
08/21/1991 | EP0442757A2 Therapeutic nucleosides |
08/21/1991 | EP0442744A2 Treatment of viral disease by glycosides |
08/21/1991 | EP0442663A1 Improvements in chemical compounds |
08/21/1991 | EP0442385A2 Process for de preparation of 7-amino-3-methoxymethyl-ceph-3-em-4-carboxylic acid |
08/21/1991 | EP0441897A1 Parvovirus capsids |
08/21/1991 | EP0441832A1 Composition and treatment with biologically active peptides and certain anions. |
08/21/1991 | CA2076377A1 Use of s-adenosyl methionine as an agent against viral infections by retroviruses |
08/20/1991 | US5041648 Phenylhydrazones of β-ionone |
08/20/1991 | US5041567 Human and veterianary medicine; veneral diseases respiratory diseases, bovine mastitis |
08/20/1991 | US5041426 Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
08/20/1991 | US5041236 Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases |
08/17/1991 | WO1991012250A1 Novel antiviral and antitumor terpene hydroquinones and methods of use |
08/17/1991 | CA2075942A1 Antiviral and antitumor terpene hydroquinones and methods of use |
08/16/1991 | CA2035994A1 Chemical compounds (improvements in) |
08/14/1991 | EP0441278A1 Polysaccharides with immunomodulating properties from astragalus membranaceus and pharmaceutical compositions containing them |
08/14/1991 | EP0441071A1 Transformed shigella |